Yoshitsu (NASDAQ:TKLF) and NovelStem International (OTCMKTS:NSTM) Head-To-Head Comparison

Yoshitsu (NASDAQ:TKLF) and NovelStem International (OTCMKTS:NSTM) are both small-cap consumer staples companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation.

Insider and Institutional Ownership

6.2% of Yoshitsu shares are owned by institutional investors. Comparatively, 0.1% of NovelStem International shares are owned by institutional investors. 75.4% of Yoshitsu shares are owned by insiders. Comparatively, 13.6% of NovelStem International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Yoshitsu and NovelStem International’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Yoshitsu	$169.72 million	0.19	-$8.05 million	N/A	N/A
NovelStem International	$10,000.00	1,115.28	-$770,000.00	N/A	N/A

NovelStem International has lower revenue, but higher earnings than Yoshitsu.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Yoshitsu and NovelStem International, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Yoshitsu	0	0	0	0	N/A
NovelStem International	0	0	0	0	N/A

Volatility & Risk

Yoshitsu has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500. Comparatively, NovelStem International has a beta of 0.54, indicating that its share price is 46% less volatile than the S&P 500.

Profitability

This table compares Yoshitsu and NovelStem International’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Yoshitsu	N/A	N/A	N/A
NovelStem International	N/A	-319.32%	-163.45%

Summary

Yoshitsu beats NovelStem International on 6 of the 8 factors compared between the two stocks.

About Yoshitsu

Yoshitsu Co., Ltd engages in the retail and wholesale of beauty, health, and other products. It offers beauty products, such as cosmetics comprising of foundation, powder, concealer, makeup remover, eyeliner, eye shadow, brow powder, brow pencil, mascara, lip gloss, lipstick, and nail polish; skin care products consisting of facial cleanser, whitening products, sun block, moisturizer, facial mask, eye mask, eye gel, and exfoliating; and cosmetic applicators, such as brush, puff, curler, hair iron, and shaver products. The company also provides body care products, such as shampoo, conditioner, and body wash; and fragrance products consisting of perfume and cologne for women and men. In addition, the company provides facial wash, firming lotion, astringent, and moisturizer products for men; and lip balm, lotion, shampoo, soap, and essence oil for children. Further, the company offers OTC drugs for the treatment of common ailments, such as colds, headaches, stomach pain, cough, and eye strains, as well as medical supplies and devices, including bandages, masks, thermometers, disinfectant sprays, eye masks, contact lens, and contact lens cleaners and solutions. Additionally, the company provides vitamins, minerals, fiber supplements, nutritional yeast, dietary products, and other nutritional supplements; bedding and bath products, and car supplies; and food, alcoholic beverages, and miscellaneous products. It directly operates physical stores in Japan and Hong Kong; online stores in Japan, China, and Korea; and franchise stores in the United States, Canada, and the United Kingdom, as well as wholesale customers in Japan, China, the United States, and Canada. The company was incorporated in 2006 and is headquartered in Tokyo, Japan.

About NovelStem International

NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is based in Boca Raton, Florida.